Immunoassay News and Research

RSS
Epigenome-wide DNA methylation patterns in convalescent COVID-19 subjects

Epigenome-wide DNA methylation patterns in convalescent COVID-19 subjects

A cancer patient who had SARS-CoV-2 for over eight months

A cancer patient who had SARS-CoV-2 for over eight months

Investigating PREVENT-19 trial findings of serological correlates of immune protection and risk against COVID-19

Investigating PREVENT-19 trial findings of serological correlates of immune protection and risk against COVID-19

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

Natural serological evidence of SARS-CoV-2 infection in lactating cows

Natural serological evidence of SARS-CoV-2 infection in lactating cows

Mucosal COVID vaccine candidate powerfully protective in macaques

Mucosal COVID vaccine candidate powerfully protective in macaques

Study measures viral antigen and inflammatory biomarkers in CSF of COVID-19 patients in relation to neurologic symptoms and disease severity

Study measures viral antigen and inflammatory biomarkers in CSF of COVID-19 patients in relation to neurologic symptoms and disease severity

Gut microbiota linked to immunocompromised people's variable response to SARS-CoV-2 vaccination

Gut microbiota linked to immunocompromised people's variable response to SARS-CoV-2 vaccination

Anti-SARS-CoV-2 titers predict COVID severity

Anti-SARS-CoV-2 titers predict COVID severity

Serologic response to SARS-CoV-2 may predict COVID-19 severity

Serologic response to SARS-CoV-2 may predict COVID-19 severity

T-cell responses after COVID-19 and vaccinations

T-cell responses after COVID-19 and vaccinations

Study assesses the efficacy and safety of lithium treatment in patients infected with severe SARS-CoV-2

Study assesses the efficacy and safety of lithium treatment in patients infected with severe SARS-CoV-2

Study suggests aerosol transmission of antibodies may contribute to host protection against SARS-CoV-2

Study suggests aerosol transmission of antibodies may contribute to host protection against SARS-CoV-2

SARS-CoV-2 viral shedding varies widely in asymptomatic and mildly ill patients

SARS-CoV-2 viral shedding varies widely in asymptomatic and mildly ill patients

Nearly 60% of Americans infected by Omicron

Nearly 60% of Americans infected by Omicron

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Novel saliva immunoassays to detect prior SARS-CoV-2 infection

Novel saliva immunoassays to detect prior SARS-CoV-2 infection